Walleye Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Buy |
87,788
+35,826
| +69% | +$773K | 0.01% | 647 |
|
|
2025
Q1 | $863K | Sell |
51,962
-126,045
| -71% | -$2.09M | ﹤0.01% | 893 |
|
|
2024
Q4 | $3.27M | Buy |
178,007
+137,201
| +336% | +$2.52M | 0.01% | 551 |
|
|
2024
Q3 | $628K | Sell |
40,806
-63,024
| -61% | -$969K | ﹤0.01% | 1241 |
|
|
2024
Q2 | $1.69M | Buy |
103,830
+64,630
| +165% | +$1.05M | ﹤0.01% | 884 |
|
|
2024
Q1 | $725K | Sell |
39,200
-203,505
| -84% | -$3.76M | ﹤0.01% | 1203 |
|
|
2023
Q4 | $7.6M | Buy |
242,705
+144,104
| +146% | +$4.51M | 0.02% | 254 |
|
|
2023
Q3 | $2.05M | Buy |
98,601
+74,850
| +315% | +$1.56M | 0.01% | 646 |
|
|
2023
Q2 | $569K | Sell |
23,751
-395,092
| -94% | -$9.46M | ﹤0.01% | 952 |
|
|
2023
Q1 | $7.88M | Buy |
418,843
+290,923
| +227% | +$5.48M | 0.12% | 182 |
|
|
2022
Q4 | $2.04M | Sell |
127,920
-81,609
| -39% | -$1.3M | 0.04% | 463 |
|
|
2022
Q3 | $3.43M | Sell |
209,529
-25,998
| -11% | -$425K | 0.07% | 286 |
|
|
2022
Q2 | $3.32M | Buy |
235,527
+212,185
| +909% | +$2.99M | 0.09% | 240 |
|
|
2022
Q1 | $565K | Sell |
23,342
-41,433
| -64% | -$1M | 0.02% | 914 |
|
|
2021
Q4 | $1.51M | Sell |
64,775
-53,501
| -45% | -$1.25M | 0.05% | 395 |
|
|
2021
Q3 | $1.97K | Buy |
118,276
+99,276
| +523% | +$1.65K | 0.06% | 218 |
|
|
2021
Q2 | $463 | Buy |
+19,000
| New | +$463 | 0.02% | 755 |
|
|
2020
Q1 | – | Sell |
-830
| Closed | -$36K | – | 492 |
|
|
2019
Q4 | $36K | Sell |
830
-7,043
| -89% | -$305K | ﹤0.01% | 543 |
|
|
2019
Q3 | $283K | Buy |
+7,873
| New | +$283K | 0.02% | 125 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 472 |
|